Latest Regulatory News

ACDC Metals has reported encouraging mineralogy results from its Goschen Central Rare Earth Elements project, reinforcing its strategic value amid rising geopolitical interest. The company maintains a solid cash balance to support ongoing development and exploration activities.

Estrella Resources has reported multiple high-grade manganese intersections at its Ira Miri project, including assays up to 58% manganese, and received regulatory approval for a 30,000-tonne bulk sample extraction. Concurrently, drilling at the Werumata limestone project has been completed with assay results pending.

Lithium Universe Limited (ASX, LU7) reports major advances in silver recycling technology alongside plans for a second lithium refinery in Texas, supported by a $2.5 million capital raise.

Resonance Health has reported record half-year revenue and strong progress in clinical trials, alongside promising new technology deployments set to enhance its global footprint.

Pacific Lime and Cement Limited reports steady progress on its Central Lime Project in Papua New Guinea, securing key government agreements and strategic partnerships while maintaining financial discipline.

Po Valley Energy has adopted its first-ever dividend policy and announced plans to pay a maiden dividend, signalling confidence in its cash flow and future growth prospects.

ioneer Ltd has raised approximately US$50.4 million through an institutional placement to fund the advancement of its Rhyolite Ridge lithium-boron project in Nevada towards a Final Investment Decision in the second half of 2026. The capital injection supports project readiness, environmental permitting, and early works for this strategically significant US critical minerals asset.

FIN Resources is gearing up to launch its maiden drilling campaign at the high-grade Cabin Lake Gold Project in Canada’s Northwest Territories, with ice road construction starting in early February and drilling expected by March.

WAM Active Limited has announced a $51.4 million entitlement offer priced at a 7.8% discount, alongside a $19.3 million placement, aiming to capitalise on its recent robust portfolio performance and deliver attractive dividends to shareholders.

Actinogen Medical’s pivotal XanaMIA trial for Alzheimer’s disease has received a green light from its independent Data Monitoring Committee to continue, reinforcing confidence in the drug’s safety and efficacy profile.

Energy Transition Minerals Ltd has raised A$24.7 million through a strongly supported placement to advance its Kvanefjeld Project and strategic acquisitions, positioning itself for growth amid ongoing arbitration challenges.

HeraMED has secured pivotal US commercial agreements and achieved a key Australian regulatory milestone, positioning itself for scalable growth in digital maternity care.